"Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Compa" by James G Krueger, Leon Kircik et al.
 

Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.

Document Type

Journal Article

Publication Date

6-1-2016

Journal

Advances in Therapy

DOI

10.1007/s12325-016-0353-2

Peer Reviewed

1

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 30
    • Policy Citations: 2
  • Usage
    • Downloads: 82
    • Abstract Views: 36
  • Captures
    • Readers: 77
  • Social Media
    • Shares, Likes & Comments: 1
see details

Share

COinS